# A Research Study Looking at How Cagrilintide Works on the Heart Rhythm in Healthy Participants

> **NCT05804162** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 107 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Cagrilintide
- **DRUG:** Cagrilintide Placebo
- **DRUG:** Moxifloxacin
- **DRUG:** Moxifloxacin Placebo

## Key facts

- **NCT ID:** NCT05804162
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-12
- **Primary completion:** 2023-08-12
- **Final completion:** 2023-09-18
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2024-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05804162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05804162, "A Research Study Looking at How Cagrilintide Works on the Heart Rhythm in Healthy Participants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05804162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*